Plenary 3: E is for
evidence - The health effects of ecstasy.
[Previous] [Next]
a) Introduction
Emanuel Sferios
Harm Reduction Hawai`i, 233 Keawe
Street, Suite 226, Honolulu, HI 96813.
Phone no: 808 – 521 – 2437 ext.
458 Fax no: 808 – 521 – 1552
E-mail: hrh@harmreduction.net
‘Dance Safe’ in the
San Francisco bay area is a harm reduction organisation serving
the ‘raving’ night club community. We operate the North American
laboratory pill analysis project where users anonymously send
pills to a lab for qualitative analysis. We do on-site testing
at local ‘raves’ and dance club events where ecstasy is used and
we provide health and safety information. We have a website (harmreduction.net)
where we have a lot of information on ecstasy and on neurotoxicity.
One of the things we try to do is translate some of the technical,
scientific data into language that the average user can understand
and in such a way that it offers some kind of practical advice.
One of the biggest questions of concern for users, next to contraindicated
medications, is "What are the long-term effects of ecstasy?"
Thus the significance of ecstasy neurotoxicity is quite high and
people want to know about it.
Doctor George Ricaurte
is from the department of neurology at John Hopkins University
in the USA, Erik Fromberg is from the Trimbos Instituut in the
Netherlands and Karl Jansen is a psychiatrist from South London
and Maudsley NHS Trust St Thomas' Hospital in England. As well
as being a medical doctor, Karl has a PhD in clinical pharmacology
at the University of Oxford and has worked full time for 6 years
on brain research as well as directly with drug addicts. The issue
of ecstasy neurotoxicity is a hotly debated topic and many of
George’s conclusions and to a lesser extent some of his methodology
have been criticised by other researchers.
Three topics need
to be addressed:-
1. What are the
long term effects? Not the effects on brain anatomy per se but
psychological and behavioural effects.
This is the question
that most users who e-mail us want to know and it is the hardest
question for us to answer, we do not know a lot.
2. What are the
implications for primary prevention?
It has been suggested
that the effects of MDMA neurotoxicity may rise many, many years
down the line. It would be so devastating that harm reduction
activists and policy makers may really want to say this is dangerous
stuff, promote primary prevention and perhaps abstention.
3. What potentials
exist for secondary prevention?
People are going
to continue to use MDMA despite its potential neurotoxicity. What
can harm reduction activists and policy makers do to minimise
the risks and potential for long term behavioural or psychological
consequences, if there are any, from the use of MDMA? One thing
that comes to mind is the use of Prozac or fluoxetine as a preventative
measure. It has been shown in some animal studies that the administration
of Prozac prevents the neurotoxic damage in lab animals. Regulating
the dose level and on-site analysis can also help so that users
can know how much they are taking because neurotoxicity may be
related directly to how much you take and how frequently. What
kind of advice should we give to the user to avoid the potential
effects? Core body temperature has also been implicated in neurotoxicity
and poly-drug use.
[Previous]
[Next]
|